The report "
Global HPV Testing And Pap Test Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast " added by DecisionDatabases.com to its vast repository provides market insights, facts, historical data, and future projections of the
HPV testing and Pap test market. This report provides information in terms of revenue for the period 2015 to 2022. Drivers, restraints, and opportunities are intellectually assessed in the research report.
HPV and Pap test is the traditional screening test done for the early detection of cervical cancer in women. The Pap test helps in the identification of altered cervical cells, and the HPV test is done to verify the presence of infected DNA in the sample cells. Over the past few years, the evolution of efficient disease management system and the presence of advance healthcare facility has changed the perception of consumers towards the adoption of a healthy lifestyle.
The HPV testing and Pap test market is majorly driven by rising occurrence of cervical cancer, growth in aging population base and increasing awareness for early-screening facility of disease. Additionally, favorable government initiatives & funding is also expected to augment market growth over the coming years. However, alteration of screening regulatory guidelines for HPV vaccination and cervical cancer along with uncertainty in the test reimbursement schemes are some of the major challenges, which may hamper the market growth of HPV testing and Pap test in the near future.
The global HPV testing and Pap test market has been segmented on the basis of type into HPV testing, co-testing, follow-up HPV testing, Pap test and HPV primary testing. The HPV and Pap test type segments are expected to attain the largest market share over the forecast period due to rising incidences of cervical cancer along with growing awareness for the screening test. The HPV testing and Pap test market has been further segmented based on applications into Pap test, vaginal cancer screening and cervical cancer screening. The cervical cancer is one of the major application segments and is projected to grow at a significant rate over the forecast period owing to rising occurrence of cervical related disease and favorable government initiatives towards the screening test. Further, the HPV testing and Pap test market has been segmented based on end user into laboratories, physician’s offices & clinics and hospitals. The hospital is the leading end-user segment and is anticipated to grow at the highest CAGR over the coming years on account of rising number of diagnostic tests in hospitals along with the availability of advanced technologies in no time.
Geographically, the report segments the global HPV testing and Pap test market into five major regions. North America is a major market for HPV testing and Pap test and is expected to grow at a considerable rate in the near future due to rising geriatric population along with the easy availability of screening tests in the region. Asia Pacific is one of the fastest growing markets and is anticipated to grow at a significant rate over the forecast period owing to rising consumer awareness for the screening test, high purchasing power and favorable government initiative in the region.
The key players include Abbott Laboratories, Qiagen N.V., Roche Diagnostics, Hologic, Inc., Becton, Dickinson and Company, Quest Diagnostics, Onco Health Corporation, Seegene, Inc., Femasys Inc., and Arbor Vita Corporation.
In May 2015, The Australian Government has acknowledged the recommendations of MSAC (the Medical Services Advisory Committee) for the replacement of Pap test with primary HPV (human papillomavirus) test for cervical screening.
Other Related Reports
About-Us:
DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.
Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise and meaningful data at a lightning speed.
For more details:
DecisionDatabases.com
E-Mail:
[email protected]
Phone: +91 99 28 237112
Web: www.decisiondatabases.com
